We are live on ! Find out more
LC

Lunate Capital Portfolio holdings

AUM $196M
1-Year Est. Return 84.21%
This Fund
S&P 500
This Quarter Est. Return
-14.65%
1 Year Est. Return
+84.21%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$171M
AUM Growth
–
Cap. Flow
+$193M
Cap. Flow %
112.81%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$89.1M
2
SAIL
SailPoint Inc
SAIL
+$65.4M
3
LINE
Lineage Inc
LINE
+$35M
4
NMRA icon
Neumora Therapeutics
NMRA
+$3.64M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 46.6%
2 Technology 32.85%
3 Real Estate 20.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$40.9B
$77.7M 45.36%
+2,196,200
New +$89.1M
SAIL
2
SailPoint Inc
SAIL
$9.17B
$56.3M 32.85%
+3,000,000
New +$65.4M
LINE
3
Lineage Inc
LINE
$9.76B
$35.2M 20.55%
+600,000
New +$35M
NMRA icon
4
Neumora Therapeutics
NMRA
$306M
$2.12M 1.24%
+2,124,143
New +$3.64M

Similar funds

NWA
Navis Wealth Advisors Rye Brook, New York $196M AUM 33.05% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
LWA
Legacy Wealth Advisors Miami, Florida $196M AUM
CCP
Cyrus Capital Partners New York $196M AUM 123.68% 1-Year Est. Return
PAM
Peninsula Asset Management Bradenton, Florida $196M AUM 10.62% 1-Year Est. Return
MAMF
Mirabaud Asset Management (France) Paris, France $196M AUM
DWG
Darden Wealth Group Ann Arbor, Michigan $196M AUM 48.82% 1-Year Est. Return
CPRPA
Cerity Partners Retirement Plan Advisors New York $196M AUM

Lunate Capital's Q1 2025 Portfolio in Review

Q1 2025 is the first quarter with a 13F filing on record for Lunate Capital, which disclosed 4 positions worth $171M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Revolution Medicines: 2,196,200 shares worth $77.7M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, followed by Technology and Real Estate.

  • Lunate Capital's largest Q1 2025 buy was Revolution Medicines: 2,196,200 shares worth $77.7M.
  • Lunate Capital's ten largest holdings make up 100% of its $171M portfolio in Q1 2025.
  • Lunate Capital disclosed 4 positions in Q1 2025, its first 13F filing on record.

Based on Lunate Capital's 13F filing for Q1 2025, filed 25 Apr 2025.